HL
ONCY

HeadInvest LLC’s Oncolytics Biotech ONCY Stock Holding History

HeadInvest LLC’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.5K Hold
44,700
– – 0.01% 217
2026
Q1 		$37.9K Hold
44,700
– – 0.01% 225
2025
Q4 		$39.1K Hold
44,700
– – 0.01% 215
2025
Q3 		$62.6K Sell
44,700
-134
-0.3% -$150 0.01% 211
2025
Q2 		$34.7K Buy
44,834
+20,000
+81% +$10.6K 0.01% 206
2025
Q1 		$13.7K Buy
24,834
+5,000
+25% +$3.66K ﹤0.01% 235
2024
Q4 		$18.1K Buy
19,834
+2,400
+14% +$2.5K ﹤0.01% 231
2024
Q3 		$15.2K Hold
17,434
– – ﹤0.01% 240
2024
Q2 		$17.3K Buy
17,434
+900
+5% +$980 ﹤0.01% 225
2024
Q1 		$17.5K Buy
16,534
+5,000
+43% +$5.59K ﹤0.01% 235
2023
Q4 		$15.6K Hold
11,534
– – ﹤0.01% 230
2023
Q3 		$24.1K Hold
11,534
– – 0.01% 439
2023
Q2 		$23.4K Buy
+11,534
New +$19.2K 0.01% 225

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

HeadInvest LLC's ONCY Position: Q2 2026 in Review

HeadInvest LLC held its Oncolytics Biotech (ONCY) position steady in Q2 2026 at 44,700 shares worth $42.5K. The position accounts for 0.01% of the portfolio, ranked #217.

HeadInvest LLC first reported a position in ONCY in Q2 2023 and has held it in 13 quarters since. The position peaked at $62.6K in Q3 2025. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • HeadInvest LLC held 44,700 shares of Oncolytics Biotech worth $42.5K as of Q2 2026.
  • HeadInvest LLC left its Oncolytics Biotech share count unchanged in Q2 2026.
  • Oncolytics Biotech made up 0.01% of HeadInvest LLC's portfolio in Q2 2026, its #217 holding.
  • HeadInvest LLC first reported a position in Oncolytics Biotech in Q2 2023 and has held it in 13 quarters since.
  • HeadInvest LLC's Oncolytics Biotech position peaked at $62.6K in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on HeadInvest LLC's 13F filing for Q2 2026, filed 14 Aug 2026.